Change in Mortality from Coronary Heart Disease and Stroke in Arkansas (1979 to 2007)

      Coronary heart disease (CHD)- and stroke-related mortality rates have been greater in the Southern states than in the rest of the United States. Although a sustained decrease in mortality from CHD and stroke has occurred in the United States during the past 3 decades, it is not known whether a similar decrease occurred in the Southern states. We examined CHD- and stroke-related deaths from 1979 to 2007 in Arkansas and observed a marked and steady decrease in both death rates. A concurrent increase occurred in the prevalence of obesity, hypertension, and diabetes mellitus, with a decrease in physical inactivity and poverty during this period. However, we noted a significant decrease in the per capita cigarette sales in Arkansas that closely paralleled the decrease in CHD- and stroke-related deaths. In conclusion, although the extensive use of cardioprotective drugs, as well as coronary revascularization, might have contributed to the decrease, we have provided evidence to suggest that the decrease in cigarette smoking was a very important factor in the decrease in CHD- and stroke-related mortality.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Heart Association
        Heart disease and stroke statistics—2010 update.
        (Accessed on May 19, 2010)
        • American Heart Association
        Heart disease and stroke statistics—2010 update.
        (Accessed on May 19, 2010)
        • McQueen M.J.
        • Lonn E.
        • Gerstein H.C.
        • Bosch J.
        • Yusuf S.
        The HOPE (Heart Outcomes Prevention Evaluation) study and its consequences.
        Scand J Clin Lab Invest Suppl. 2005; 240: 143-156
        • Yusuf S.
        • Hawken S.
        • Ounpuu S.
        • Dans T.
        • Avezum A.
        • Lanas F.
        • McQueen M.
        • Budaj A.
        • Pais P.
        • Varigos J.
        • Lisheng L.
        Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
        Lancet. 2004; 364: 937-952
        • Messer K.
        • Trinidad D.R.
        • Al-Delaimy W.K.
        • Pierce J.P.
        Smoking cessation rates in the United States: a comparison of young adult and older smokers.
        Am J Public Health. 2008; 98: 317-322
        • Ostchega Y.
        • Dillon C.F.
        • Hughes J.P.
        • Carroll M.
        • Yoon S.
        Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988–2004.
        J Am Geriatr Soc. 2007; 55: 1056-1065
        • Hyre A.D.
        • Muntner P.
        • Menke A.
        • Raggi P.
        • He J.
        Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
        Ann Epidemiol. 2007; 17: 548-555
        • Lim S.S.
        • Gaziano T.A.
        • Gakidou E.
        • Reddy K.S.
        • Farzadfar F.
        • Lozano R.
        • Rodgers A.
        Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs.
        Lancet. 2007; 370: 2054-2062
        • Rich D.Q.
        • Gaziano J.M.
        • Kurth T.
        Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States.
        Stroke. 2007; 38: 2221-2227
        • Hajjar I.
        • Kotchen T.
        Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data.
        J Nutr. 2003; 133: 211-214
        • Orzechowski W.
        • Walker R.
        The Tax Burden on Tobacco: Historical Compilation.
        Orzechowski and Walker Consulting, Arlington, Virginia2008
        • Centers for Disease Control and Prevention
        Behavioral Risk Factor Surveillance System.
        (Accessed on December 2, 2009)
        • Draper N.R.
        • Smith H.
        Applied Regression Analysis.
        3rd ed. Wiley, New York1998
        • Cooney M.T.
        • Dudina A.
        • Whincup P.
        • Capewell S.
        • Menotti A.
        • Jousilahti P.
        • Njølstad I.
        • Oganov R.
        • Thomsen T.
        • Tverdal A.
        • Wedel H.
        • Wilhelmsen L.
        • Graham I.
        • Score Investigators
        Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: 541-549
        • Kireyev D.
        • Yun E.C.
        • Page B.J.
        • Boden W.E.
        Medical therapy in acute coronary syndromes: which medicines and at what doses?.
        Curr Cardiol Rep. 2009; 11: 267-275
        • Cooper-DeHoff R.M.
        • Handberg E.M.
        • Mancia G.
        • Zhou Q.
        • Champion A.
        • Legler U.F.
        • Pepine C.J.
        INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
        Expert Rev Cardiovasc Ther. 2009; 7: 1329-1340
        • Toyoda K.
        Pharmacotherapy for the secondary prevention of stroke.
        Drugs. 2009; 69: 633-647
        • Amarenco P.
        • Labreuche J.
        Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.
        Lancet Neurol. 2009; 8: 453-463
        • Agency for Healthcare Research and Quality
        National healthcare quality report.
        (Accessed on August 24, 2010)
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with and without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Yusuf S.
        • Zucker D.
        • Peduzzi P.
        • Fisher L.D.
        • Kennedy J.W.
        • Davis K.
        • Killip T.
        • Norris R.
        • Morris C.
        • Mathur R.
        • Varnauskas E.
        • Chalmers T.C.
        Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists collaboration.
        Lancet. 1994; 344: 563-570
        • Strazzullo P.
        • D'Elia L.
        • Kandala N.
        • Cappuccio F.P.
        Salt intake, stroke and cardiovascular disease: meta-analysis of prospective studies.
        BMJ. 2009; 339: b4567
        • Micha R.
        • Wallace S.K.
        • Mozaffarian D.
        Red and processed meat consumption and risk of incident coronary heart disease, stroke and diabetes mellitus: a systematic review and meta-analysis.
        Circulation. 2010; 121: 2271-2283

      Linked Article